Sandryne David
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandryne David has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Frédéric Leblond
Polytechnique Montreal, Montreal, Canada
3 shared publications - Frédérick Dallaire
Polytechnique Montreal
3 shared publications - Trang Tran
Polytechnique Montreal
3 shared publications - Guillaume Sheehy
CHU Montreal, Research Centre, Montreal, Quebec, Canada
2 shared publications - Sarkis Meterissian
Department of Surgery and Oncology, McGill University, Montreal, QC H4A 3J1, Canada
2 shared publications Atilla Omeroglu
McGill University Health Center, Department of Pathology, Montreal, Quebec, Canada
1 shared publication
Latest Publications
- Open Access
- 1 June 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (06) , 065004-16
Macroscopic inelastic scattering imaging using a hyperspectral line-scanning system identifies invasive breast cancer in lumpectomy and mastectomy specimens
SignificanceOf patients with early-stage breast cancer, 60% to 75% undergo breast-conserving surgery. Of those, 20% or more need a second surgery because of an incomplete tumor resection only discovered days after surgery. An intraoperative imaging technology allowing cancer detection on the margins of breast specimens could reduce re-excision procedure rates and improve patient survival.AimWe aimed to develop an experimental protocol using hyperspectral line-scanning Raman spectroscopy to image fresh breast specimens from cancer patients. Our objective was to determine whether macroscopic specimen images could be produced to distinguish invasive breast cancer from normal tissue structures.ApproachA hyperspectral inelastic scattering imaging instrument was used to interrogate eight specimens from six patients undergoing breast cancer surgery. Machine learning models trained with a different system to distinguish cancer from normal breast structures were used to produce tissue maps with a field-of-view of 1 cm2 classifying each pixel as either cancer, adipose, or other normal tissues. The predictive model results were compared with spatially correlated histology maps of the specimens.ResultsA total of eight specimens from six patients were imaged. Four of the hyperspectral images were associated with specimens containing cancer cells that were correctly identified by the new ex vivo pathology technique. The images associated with the remaining four specimens had no histologically detectable cancer cells, and this was also correctly predicted by the instrument.ConclusionsWe showed the potential of hyperspectral Raman imaging as an intraoperative breast cancer margin assessment technique that could help surgeons improve cosmesis and reduce the number of repeat procedures in breast cancer surgery.
- 1 June 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (06) , 065004-16
Open AccessMacroscopic inelastic scattering imaging using a hyperspectral line-scanning system identifies invasive breast cancer in lumpectomy and mastectomy specimens
SignificanceOf patients with early-stage breast cancer, 60% to 75% undergo breast-conserving surgery. Of those, 20% or more need a second surgery because of an incomplete tumor resection only discovered days after surgery. An intraoperative imaging technology allowing cancer detection on the margins of breast specimens could reduce re-excision procedure rates and improve patient survival.AimWe aimed to develop an experimental protocol using hyperspectral line-scanning Raman spectroscopy to image fresh breast specimens from cancer patients. Our objective was to determine whether macroscopic specimen images could be produced to distinguish invasive breast cancer from normal tissue structures.ApproachA hyperspectral inelastic scattering imaging instrument was used to interrogate eight specimens from six patients undergoing breast cancer surgery. Machine learning models trained with a different system to distinguish cancer from normal breast structures were used to produce tissue maps with a field-of-view of 1 cm2 classifying each pixel as either cancer, adipose, or other normal tissues. The predictive model results were compared with spatially correlated histology maps of the specimens.ResultsA total of eight specimens from six patients were imaged. Four of the hyperspectral images were associated with specimens containing cancer cells that were correctly identified by the new ex vivo pathology technique. The images associated with the remaining four specimens had no histologically detectable cancer cells, and this was also correctly predicted by the instrument.ConclusionsWe showed the potential of hyperspectral Raman imaging as an intraoperative breast cancer margin assessment technique that could help surgeons improve cosmesis and reduce the number of repeat procedures in breast cancer surgery.
- 7 October 2023
- Published by Springer Nature
- p. 17-28
Towards Real-Time Confirmation of Breast Cancer in the OR Using CNN-Based Raman Spectroscopy Classification
- 7 October 2023
- Published by Springer Nature
- p. 17-28
Towards Real-Time Confirmation of Breast Cancer in the OR Using CNN-Based Raman Spectroscopy Classification
- Open Access
- 1 March 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (03) , 036009-18
In situ Raman spectroscopy and machine learning unveil biomolecular alterations in invasive breast cancer
Breast cancer is the most diagnosed cancer worldwide. It accounted for 1 in 8 cancer diagnoses and 685,000 deaths in 2020.1,2 It is the leading cause of cancer mortality in women and may affect men in rare cases.1,3 Early diagnosis and effective treatment are critical factors for survival.4 Ductal carcinoma is the most common type of breast cancer, and it originates in epithelial cells lining the interior of the ducts that carry milk from glands to the nipple. Lobular carcinoma, the second most common breast cancer type, originates from cells within the lobules, which are groups of glands connected to the duct. These carcinomas may be in situ or invasive.5 In situ cancers have not grown into surrounding tissues, whereas invasive cancer cells have initiated molecular processes allowing them to spread beyond the tissue of origin.5 There are two major types of in situ breast cancers: ductal carcinoma in situ and lobular carcinoma in situ.6
- 1 March 2023
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 28 (03) , 036009-18
Open AccessIn situ Raman spectroscopy and machine learning unveil biomolecular alterations in invasive breast cancer
Breast cancer is the most diagnosed cancer worldwide. It accounted for 1 in 8 cancer diagnoses and 685,000 deaths in 2020.1,2 It is the leading cause of cancer mortality in women and may affect men in rare cases.1,3 Early diagnosis and effective treatment are critical factors for survival.4 Ductal carcinoma is the most common type of breast cancer, and it originates in epithelial cells lining the interior of the ducts that carry milk from glands to the nipple. Lobular carcinoma, the second most common breast cancer type, originates from cells within the lobules, which are groups of glands connected to the duct. These carcinomas may be in situ or invasive.5 In situ cancers have not grown into surrounding tissues, whereas invasive cancer cells have initiated molecular processes allowing them to spread beyond the tissue of origin.5 There are two major types of in situ breast cancers: ductal carcinoma in situ and lobular carcinoma in situ.6